Sign in

CIK 0001671858

  • Non-accelerated filer
  • Smaller reporting company

ARS Pharmaceuticals, Inc.

Sign in to watch
Ticker
SPRY
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
811489190
Phone
+1 858-771-9307
Business address
11682 EL CAMINO REAL, SUITE 300, SAN DIEGO, CA, 92130
Former names
Silverback Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-06-24 RA CAPITAL MANAGEMENT, L.P. Director Grant or award · Stock Option (Right to Buy) +30,000 30,000
2025-06-25 RA CAPITAL MANAGEMENT, L.P. Director Grant or award · Stock Option (Right to Buy) +30,000 30,000
2024-06-20 RA CAPITAL MANAGEMENT, L.P. Director Grant or award · Stock Option (Right to Buy) +40,000 40,000
2024-03-27 RA CAPITAL MANAGEMENT, L.P. Director Purchase +505,954 $9.79 $5.0M 9,958,073
2024-03-26 RA CAPITAL MANAGEMENT, L.P. Director Purchase +457,745 $9.55 $4.4M 9,452,119
2024-03-25 RA CAPITAL MANAGEMENT, L.P. Director Purchase +437,600 $9.06 $4.0M 8,994,374
2023-09-21 RA CAPITAL MANAGEMENT, L.P. Director Purchase +2,508,691 $2.97 $7.5M 8,365,465
2023-09-21 RA CAPITAL MANAGEMENT, L.P. Director Purchase +191,309 $3.83 $733K 8,556,774
2023-08-29 RA CAPITAL MANAGEMENT, L.P. Director Purchase +3,750,000 $6.20 $23.3M 5,856,774
2023-06-27 RA CAPITAL MANAGEMENT, L.P. Director Grant or award · Stock Option (Right to Buy) +40,000 40,000
2022-11-08 RA CAPITAL MANAGEMENT, L.P. Director Grant or award +2,106,774 2,106,774
2022-11-08 RA CAPITAL MANAGEMENT, L.P. Director Grant or award +902,904 902,904

Page 1 of 1 · 12 trades